Lastacaft
Brand Name: Lastacaft
Generic Name: Alcaftadine
Active
Registration Number
DR-XY43136
Dosage Form
Sterile Ophthalmic Solution
Issuance Date
July 31, 2023
Expiry Date
August 9, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength2.5 mg/ mL (0.25%w/v)
PackagingLDPE Opaque white plastic bottle in 3 mL (net content, Box of 1's; LDPE Opaque white plastic bottle in 1 mL (PS) Box of 1's
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antihistamine
A
Application
Automatic Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
AlcaftadineActive
Monograph: Alcaftadine